Medical Oncologist
EGFR-mutated lung cancer treatment
Gefitinib Plus Chemotherapy: — Does Adding Chemo Actually Help?
Gefitinib targets cancer cells that depend on an EGFR mutation to grow. Chemotherapy attacks cancer cells by a different route. Understanding what each drug contributes helps you make sense of why your oncologist may recommend both.
Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026
- Two different mechanisms — Gefitinib blocks the EGFR signal that drives tumour growth. Chemotherapy attacks dividing cells by an entirely different route.
- Evidence supports it — An Indian clinical trial showed the combination improved outcomes compared to gefitinib alone in EGFR-mutated lung cancer.
- More side effects to manage — The combination is more demanding than gefitinib alone. Your fitness level is a key part of the decision.
- The timing is carefully planned — The two treatments are given on a schedule designed to minimise interference between them.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
For EGFR-mutated lung cancer, evidence — including a major Indian clinical trial — suggests that adding platinum-based chemotherapy to gefitinib improves outcomes compared to gefitinib alone. Gefitinib targets EGFR-dependent cancer cells; chemotherapy targets cells that do not depend on EGFR. Whether the combination is right for you depends on your fitness and your oncologist's assessment.
Why would you add chemotherapy to a drug that already targets the cancer?
Gefitinib works by blocking a specific signal — the EGFR pathway — that your cancer cells depend on to grow and divide. In EGFR-mutated lung cancer, that is a direct hit on the driver of the disease.
The problem is that not every cell in a tumour behaves identically. Some cells may not depend on EGFR at all, or may develop independence over time. Chemotherapy attacks dividing cells through a different mechanism — one that does not require an EGFR mutation to be effective.
The rationale for combining them is to close that gap: gefitinib handles the EGFR-driven cells; chemotherapy handles the rest.
What does each drug name on your prescription actually mean?
- EGFR mutation
- A change in the EGFR gene that makes cancer cells dependent on the EGFR signal to grow. It is the reason gefitinib was prescribed in the first place.
- Gefitinib (Iressa)
- A targeted tablet taken once daily. It blocks the EGFR protein so that cancer cells cannot receive the growth signal they rely on.
- Carboplatin
- A platinum-based chemotherapy drug given by drip. It damages the DNA inside rapidly dividing cells so they cannot replicate — regardless of whether those cells carry an EGFR mutation.
- Pemetrexed
- A chemotherapy drug given by drip alongside carboplatin. It works by blocking a step in cell division that does not depend on EGFR, reaching cancer cells that gefitinib cannot.
- Maintenance phase
- The period after the planned chemotherapy cycles finish. Gefitinib continues, and sometimes one of the chemotherapy drugs continues alongside it, to suppress the cancer over a longer period.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
How is the combination given?
Fitness check before starting
Blood tests, heart function and your general performance status are assessed first. The combination is more demanding than gefitinib alone, so your team confirms you are well enough to receive it before treatment begins.
Chemotherapy by drip on a fixed cycle
You attend day care for carboplatin and pemetrexed given by intravenous infusion. These cycles are spaced at regular intervals — your oncologist will tell you the exact schedule before you start.
Gefitinib tablet taken daily at home
You take gefitinib by mouth every day throughout the chemotherapy cycles, including on days when you are not attending for your drip.
Planned number of cycles, then scan review
The chemotherapy component runs for a planned number of cycles. After that, your response is assessed by imaging before your team decides what comes next.
Maintenance continues beyond the cycles
Once the chemotherapy cycles are complete, gefitinib continues. Your oncologist will discuss whether one of the chemotherapy drugs continues alongside it in the maintenance phase.
What side effects should you expect from the combination?
The combination carries the side effects of both drugs. Fatigue is common and is often more pronounced than with gefitinib alone.
Gefitinib's typical effects — a skin rash and loose stools — continue throughout the treatment. The chemotherapy adds nausea, a lowered blood count, and an increased infection risk in the days after each drip. Your team will prescribe anti-nausea medicines and will check your blood count before each cycle.
The skin rash from gefitinib is uncomfortable but is not a reason to stop treatment. Tell your team about it so they can manage it alongside you.
Is the combination right for every patient on gefitinib?
No. The combination is more intensive than gefitinib alone, and some patients are not fit enough to receive platinum-based chemotherapy alongside it. Older patients and those with significant other health conditions may do better on gefitinib alone.
The decision also depends on which EGFR mutation you have and whether other targeted options — such as third-generation EGFR inhibitors — are being considered for your situation.
Ask your oncologist to explain which regimen they are recommending and why it suits your specific case. A clear answer to that question is reasonable to expect.
Explore 75 more Lung Cancer Targeted Medicines topics
Drug Deep Dive: Gefitinib (Iressa)
- Diarrhoea on Gefitinib: Home Management and Warning Signs
- Diet and Nutrition While on Gefitinib
- Fertility, Pregnancy and Contraception on Gefitinib
- Gefitinib (Iressa, Geftinat, Geftib): The Complete Patient Guide
- Gefitinib Myths: 'It's Only for Poor Patients' and Other Half-Truths
- Gefitinib Plus Chemotherapy: Does Adding Chemo Actually Help?
- Gefitinib Price in India: Brand, Generic and Monthly Cost
- Gefitinib Rash: Why It Appears in Week Two and How to Treat It
- Gefitinib Side Effects: The Complete List and Timeline
- Gefitinib Success Rate and Survival: An Honest Look at the Numbers
- Gefitinib and Antacids: The Interaction That Silently Reduces Absorption
- Gefitinib in Early-Stage vs Advanced Lung Cancer: Different Goals
- Gefitinib in Elderly Patients and Those With Other Illnesses
- Gefitinib vs Osimertinib: Making the Decision When Cost Matters
- How Does Gefitinib Work? The First-Generation EGFR Inhibitor Explained
- How Long Does Gefitinib Take to Work?
- How Long Will You Stay on Gefitinib?
- Raised Liver Enzymes on Gefitinib: What Your LFT Report Means
- T790M Testing After Gefitinib Stops Working: The Next Step Explained
- Taking Gefitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Gefitinib
- When Gefitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Gefitinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Gefitinib?
- Work, Travel and Daily Life on Gefitinib
Drug Deep Dive: Alectinib (Alecensa)
- Alectinib (Alecensa, Alectinib): The Complete Patient Guide
- Alectinib After Surgery for Early-Stage ALK-Positive Lung Cancer
- Alectinib Myths: Is ALK-Positive Cancer 'Curable'?
- Alectinib Price in India: Brand, Generic and Monthly Cost
- Alectinib Side Effects: The Complete List and Timeline
- Alectinib Success Rate and Survival: An Honest Look at the Numbers
- Alectinib and Brain Metastases: How It Protects the Brain
- Alectinib in Elderly Patients and Those With Other Illnesses
- Alectinib vs Crizotinib vs Lorlatinib: Choosing an ALK Inhibitor
- Diet and Nutrition While on Alectinib
- Do You Need Chemotherapy Alongside Alectinib?
- Drug, Food and Supplement Interactions With Alectinib
- Fertility, Pregnancy and Contraception on Alectinib
- How Does Alectinib Work? The Second-Generation ALK Inhibitor Explained
- How Long Does Alectinib Take to Work?
- How Long Will You Stay on Alectinib?
- Muscle Pain and High CPK on Alectinib: When to Worry
- Severe Sun Sensitivity on Alectinib: Preventing Serious Burns
- Taking Alectinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Alectinib
- Weight Gain, Constipation and a Slow Pulse on Alectinib
- When Alectinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Alectinib? ALK-Positive Lung Cancer
- Will Insurance or a Government Scheme Pay for Alectinib?
- Work, Travel and Daily Life on Alectinib
Drug Deep Dive: Osimertinib (Tagrisso)
- Adjuvant Osimertinib After Lung Cancer Surgery: Three Years of Tablets
- Breathlessness or New Cough on Osimertinib: Recognising Lung Injury (ILD)
- Diet and Nutrition While on Osimertinib
- Drug, Food and Supplement Interactions With Osimertinib
- Fertility, Pregnancy and Contraception on Osimertinib
- Heart Rhythm and Ejection Fraction Changes on Osimertinib
- How Does Osimertinib Work? The Third-Generation EGFR Inhibitor Explained
- How Long Does Osimertinib Take to Work?
- How Long Will You Stay on Osimertinib?
- Osimertinib (Tagrisso): The Complete Patient Guide
- Osimertinib Myths: Clear Scans, Stopping Early and Generic Quality
- Osimertinib Price in India: Brand, Generic and Monthly Cost
- Osimertinib Side Effects: The Complete List and Timeline
- Osimertinib Success Rate and Survival: An Honest Look at the Numbers
- Osimertinib With Chemotherapy: Who Actually Benefits From the Combination?
- Osimertinib and Brain Metastases: Why It Works Inside the Brain
- Osimertinib in Elderly Patients and Those With Other Illnesses
- Osimertinib vs Gefitinib and Erlotinib: Is the Costlier Drug Worth It?
- Rash, Dry Skin and Nail Problems on Osimertinib
- Taking Osimertinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Osimertinib
- When Osimertinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Osimertinib? EGFR-Mutant Lung Cancer
- Will Insurance or a Government Scheme Pay for Osimertinib?
- Work, Travel and Daily Life on Osimertinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Why not just use gefitinib on its own?
Gefitinib alone is an established treatment for EGFR-mutated lung cancer, and many patients do well on it. The case for adding chemotherapy is that some cancer cells in a tumour may not depend on the EGFR pathway, and chemotherapy can target those. Whether the additional benefit outweighs the additional burden is a decision your oncologist makes based on your cancer biology and your fitness — not a judgement that applies the same way to every patient.
Does the combination definitely work better than gefitinib alone?
The evidence suggests it improves outcomes for a proportion of patients with EGFR-mutated lung cancer. A major Indian clinical trial published in the Journal of Clinical Oncology found the combination was associated with improved survival compared to gefitinib alone, and NCCN and ESMO have acknowledged this evidence in their guidance. Whether 'better' applies to your specific situation is a clinical judgement based on your results — not a guarantee that holds for every person.
Will the side effects be much worse than with gefitinib alone?
Yes, the combination typically causes more side effects than gefitinib alone. Fatigue is more pronounced. Chemotherapy adds nausea, a lowered blood count, and an infection risk in the days after each drip. Your team will give you medicines to manage nausea and will monitor your blood before each cycle. Most effects are manageable, but the combination is more demanding — which is exactly why fitness is assessed carefully before starting.
How long does the treatment last?
The chemotherapy component runs for a planned number of cycles at fixed intervals, after which there is a scan-based review. Gefitinib continues beyond those cycles — sometimes alongside one of the chemotherapy drugs in the maintenance phase. Your oncologist should give you the full planned timeline before you begin, so you know what to expect and can plan around it.
What happens if the combination stops working?
If the cancer progresses, your oncologist will investigate why. Some cancers develop a resistance mutation — a common one is called T790M — that makes them less responsive to first-generation EGFR inhibitors like gefitinib. A repeat biopsy or a liquid biopsy can identify whether this has happened. If a specific resistance mechanism is found, there are subsequent treatment options your team will discuss based on what the testing shows.
Is this combination available at CION?
The combination can be administered as day care at CION centres. Response-assessment scans such as PET-CT are coordinated with partner imaging centres. If you want to know whether this regimen is appropriate for you specifically, your oncologist at CION will review your biopsy and biomarker results and walk you through the options that apply to your situation.